Toronto Dominion Bank’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.23M Buy
7,766
+1,379
+22% +$396K ﹤0.01% 791
2025
Q1
$1.97M Buy
6,387
+848
+15% +$261K ﹤0.01% 768
2024
Q4
$1.95M Sell
5,539
-7
-0.1% -$2.47K ﹤0.01% 752
2024
Q3
$1.99M Buy
5,546
+1,021
+23% +$366K ﹤0.01% 659
2024
Q2
$1.44M Buy
4,525
+37
+0.8% +$11.8K ﹤0.01% 723
2024
Q1
$1.03M Sell
4,488
-1,620
-27% -$372K ﹤0.01% 770
2023
Q4
$1.34M Sell
6,108
-9,834
-62% -$2.16M ﹤0.01% 785
2023
Q3
$3.6M Sell
15,942
-2,179
-12% -$492K 0.01% 657
2023
Q2
$4M Buy
18,121
+4,283
+31% +$945K 0.01% 658
2023
Q1
$3.1M Buy
13,838
+11,538
+502% +$2.58M 0.01% 682
2022
Q4
$639K Sell
2,300
-2,400
-51% -$667K ﹤0.01% 895
2022
Q3
$984K Buy
+4,700
New +$984K ﹤0.01% 887
2022
Q1
Sell
-70,000
Closed -$15.1M 1996
2021
Q4
$15.1M Buy
+70,000
New +$15.1M 0.02% 394
2019
Q2
Sell
-7,854
Closed -$922K 1305
2019
Q1
$922K Buy
7,854
+1,984
+34% +$233K ﹤0.01% 739
2018
Q4
$639K Buy
5,870
+1,139
+24% +$124K ﹤0.01% 745
2018
Q3
$605K Buy
4,731
+421
+10% +$53.8K ﹤0.01% 757
2018
Q2
$487K Buy
4,310
+1,351
+46% +$153K ﹤0.01% 789
2018
Q1
$332K Buy
2,959
+398
+16% +$44.7K ﹤0.01% 790
2017
Q4
$379K Buy
2,561
+658
+35% +$97.4K ﹤0.01% 775
2017
Q3
$223K Buy
1,903
+1,351
+245% +$158K ﹤0.01% 800
2017
Q2
$72K Buy
552
+88
+19% +$11.5K ﹤0.01% 860
2017
Q1
$63K Buy
464
+87
+23% +$11.8K ﹤0.01% 861
2016
Q4
$54K Sell
377
-8
-2% -$1.15K ﹤0.01% 847
2016
Q3
$45K Buy
385
+136
+55% +$15.9K ﹤0.01% 863
2016
Q2
$26K Sell
249
-1
-0.4% -$104 ﹤0.01% 864
2016
Q1
$28K Buy
250
+237
+1,823% +$26.5K ﹤0.01% 841
2015
Q4
$2K Buy
+13
New +$2K ﹤0.01% 826